Rationale: Eradication and suppression of Pseudomonas aeruginosa is a key priority in
national guidelines for bronchiectasis and is a major focus of drug development and clinical …

Bronchiectasis refers to abnormal dilatation of the bronchi. Airway dilatation can lead to
failure of mucus clearance and increased risk of infection. Pathophysiological mechanisms …

We evaluated the efficacy and safety of ciprofloxacin dry powder for inhalation (DPI) in
patients with non-cystic fibrosis bronchiectasis, two or more exacerbations in the previous …

We evaluated the efficacy and safety of ciprofloxacin dry powder for inhalation (DPI) in
patients with non-cystic fibrosis bronchiectasis, two or more exacerbations in the previous …

This European Respiratory Society statement provides a comprehensive overview on
protracted bacterial bronchitis (PBB) in children. A task force of experts, consisting of …

Background People with non‐cystic fibrosis bronchiectasis commonly experience chronic
cough and sputum production, features that may be associated with progressive decline in …

Bronchiectasis is one of the most neglected diseases in respiratory medicine. There are no
approved therapies and few large-scale, representative epidemiological studies. The …

Cough is the single most common reason for primary care physician visits and, when
chronic, a frequent indication for specialist referrals. In children, a chronic cough (> 4 weeks) …

Medical Journal of Australia Page 1 Clinical focus 21 MJA 202 (1) · 19 January 2015 Guidelines
Of the 32 recommendations, eight are new, seven unaltered and the remaining 17 were …

Objective To examine the effect of pulmonary rehabilitation (PR)(exercise and education) or
exercise training (ET) on exercise capacity, health-related quality of life (HRQOL) …